FLAK50D V
General Information
DRACP ID DRACP01742
Peptide Name FLAK50D V
Sequence VAKLLAKALKKLL
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin FLAK peptides
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | LD50=45 µg/ml | MTT assay | 24 h | Patent |
SW480 | Colon adenocarcinoma | Carcinoma | Not available | MTT assay | 24 h | Patent |
BMKC | Skin carcinoma | Carcinoma | Not available | MTT assay | 24 h | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C68H129N17O14
Absent amino acids CDEFGHIMNPQRSTWY
Common amino acids L
Mass 162313
Pl 11.28
Basic residues 4
Acidic residues 0
Hydrophobic residues 9
Net charge 4
Boman Index 1187
Hydrophobicity 100
Aliphatic Index 195.38
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US2005/0209157A1
Patent Title Short bioactive peptides and methods for their use
Other Iinformation Patent Application; Family: 1s / 24ex; Family Jurisdictions: US; Legal Status: Discontinued; Application No: 13618605; Filed: May 24, 2005; Published: Sep 22, 2005; Earliest Priority: Mar 28, 2001
Other Published ID Not available